Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant.
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant.
复制标题
DOI:
10.1016/j.vaccine.2023.05.056
复制
发表时间:
2023-08-07
期刊:
影响因子:
5.5
通讯作者:
Wang, Xuqiu
中科院分区:
文献类型:
--
作者:
Hu, Songhua;Xiong, Chenfeng;Zhao, Yingrui;Yuan, Xin;Wang, Xuqiu
The B.1.1.529 (Omicron) variant surge has raised concerns about the effectiveness of vaccines and the impact of imprudent reopening. Leveraging over two years of county-level COVID-19 data in the US, this study aims to investigate relationships among vaccination, human mobility, and COVID-19 health outcomes (assessed via case rate and case-fatality rate), controlling for socioeconomic, demographic, racial/ethnic, and partisan factors. A set of cross-sectional models was first fitted to empirically compare disparities in COVID-19 health outcomes before and during the Omicron surge. Then, time-varying mediation analyses were employed to delineate how the effects of vaccine and mobility on COVID-19 health outcomes vary over time. Results showed that vaccine effectiveness against case rate lost significance during the Omicron surge, while its effectiveness against case-fatality rate remained significant throughout the pandemic. We also documented salient structural inequalities in COVID-19-related outcomes, with disadvantaged populations consistently bearing a larger brunt of case and death tolls, regardless of high vaccination rates. Last, findings revealed that mobility presented a significantly positive relationship with case rates during each wave of variant outbreak. Mobility substantially mediated the direct effect from vaccination to case rate, leading to a 10.276 % (95 % CI: 6.257, 14.294) decrease in vaccine effectiveness on average. Altogether, our study implies that sole reliance on vaccination to halt COVID-19 needs to be re-examined. Well-resourced and coordinated efforts to enhance vaccine effectiveness, mitigate health disparity and selectively loosen non-pharmaceutical interventions are essential to bringing the pandemic to an end.
登录
查看更多内容
DOI:
10.1056/nejmoa2119451
发表时间:
2022-04-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Andrews N;Stowe J;Kirsebom F;Toffa S;Rickeard T;Gallagher E;Gower C;Kall M;Groves N;O'Connell AM;Simons D;Blomquist PB;Zaidi A;Nash S;Iwani Binti Abdul Aziz N;Thelwall S;Dabrera G;Myers R;Amirthalingam G;Gharbia S;Barrett JC;Elson R;Ladhani SN;Ferguson N;Zambon M;Campbell CNJ;Brown K;Hopkins S;Chand M;Ramsay M;Lopez Bernal J
通讯作者:
Lopez Bernal J
影响因子:
3.7
作者:
Alagoz O;Sethi AK;Patterson BW;Churpek M;Alhanaee G;Scaria E;Safdar N
通讯作者:
Safdar N
DOI:
10.1016/j.socscimed.2020.113638
发表时间:
2021-03
期刊:
Social science & medicine (1982)
影响因子:
--
作者:
Callaghan T;Moghtaderi A;Lueck JA;Hotez P;Strych U;Dor A;Fowler EF;Motta M
通讯作者:
Motta M
影响因子:
11.7
作者:
Hu S;Xiong C;Younes H;Yang M;Darzi A;Jin ZC
通讯作者:
Jin ZC
DOI:
10.1016/j.trc.2020.102955
发表时间:
2021-03
期刊:
Transportation research. Part C, Emerging technologies
影响因子:
--
作者:
Hu S;Xiong C;Yang M;Younes H;Luo W;Zhang L
通讯作者:
Zhang L